SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




J Nucl Med. 2008; 49 (Supplement 1):211P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bishu, S.
Right arrow Articles by Smith, C.
PubMed
Right arrow Articles by Bishu, S.
Right arrow Articles by Smith, C.

Neurosciences: Basic Science

Basic Science Posters

PET measurement of regional rates of cerebral protein synthesis (rCPS) with L-[1-11C]leucine in healthy males under propofol sedation

Shrinivas Bishu1, Kathleen Schmidt1, Michael Channing3, Mei Qin1, Aaron Unterman1, Alan Zametkin2, Peter Herscovitch3, Zenaide Quezado4, William Kammerer4 and Carolyn Smith1

1 Laboratory of Cerebral Metabolism, NIMH; 2 Mood/Anxiety Disorder Program, NIMH; 3 PET Dept, CC; 4 Dept of Anesthesiology, CC, National Institutes of Health, Bethesda, Maryland

913

Objectives: The quantitative L-[1-11C]leucine PET method makes it possible to determine if rCPS changes with physiologic interventions and disease states. We studied the effect of deep propofol sedation on rCPS.

Methods: Seven males (20-24y) were studied awake and during sedation. They were dynamically scanned for 90 min following tracer injection. ROI-based analyses were used to estimate kinetic model rate constants from which the fraction of the precursor pool for protein synthesis derived from arterial plasma ({lambda}) was calculated. rCPS were calculated from the rate constants, {lambda}, and plasma leucine concentrations. Propofol was titrated to keep subjects motionless.

Results: {lambda} was ~4% higher during sedation. rCPS tended to be slightly lower, but effects were not statistically significant.

Conclusions: These preliminary results suggest deep sedation with propofol has little or no effect on rCPS. This information will facilitate using L-[1-11C]leucine to study patient groups who require sedation during scanning.

Research Support: IRP, NIMH; CC,NIH; Fragile X Research Foundation


Figure 1





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bishu, S.
Right arrow Articles by Smith, C.
PubMed
Right arrow Articles by Bishu, S.
Right arrow Articles by Smith, C.